Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 13, Issue 1, 2005, Pages 95-99

  Chen, Bao An ^a   Qian, Xi Jun ^a   Cheng, Jian ^a   Gao, Feng ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3-HYDROXYTAMOXIFEN; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; BENZYLISOQUINOLINE DERIVATIVE; DROLOXIFENE; DRUG DERIVATIVE; MESSENGER RNA; TAMOXIFEN; TETRANDRINE;

ARTICLE; BIOSYNTHESIS; CELL STRAIN K 562; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BENZYLISOQUINOLINES; BLOTTING, WESTERN; DOWN-REGULATION; DRUG SYNERGISM; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; K562 CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAMOXIFEN;

EID: 49649106519     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)